Even after seeing exceptional current value growth in 2022, it is anticipated that analgesics will continue to experience double-digit growth in 2023. This can primarily be attributed to the substantial increase in COVID-19 cases in China starting from the end of 2022, following the cessation of the zero-COVID policy.
The analyst's Analgesics in China report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.
Product coverage:
Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage:
Market sizes (historic and forecasts), company shares, brand shares and distribution data.
The analyst's Analgesics in China report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.
Product coverage:
Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage:
Market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Analgesics market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Table of Contents
ANALGESICS IN CHINAKEY DATA FINDINGSCONSUMER HEALTH IN CHINADISCLAIMERDEFINITIONS
2023 DEVELOPMENTS
PROSPECTS AND OPPORTUNITIES
CATEGORY DATA
EXECUTIVE SUMMARY
MARKET INDICATORS
MARKET DATA
APPENDIX
SOURCES
